Kailera Clinical Site

East Syracuse, New York 13057

0 studies enrolling now · 1 studies all time

What they study most

Obesity

Studies at this site

• Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes — Running, not enrolling